Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page
- ChecktodayChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.1%

- Check8 days agoChange DetectedNew study record dates added: 2026-03-31 and 2026-03-29; dates 2026-03-25 and 2026-03-04 were removed.SummaryDifference0.3%

- Check15 days agoChange DetectedAdded posted results for multiple seizure-related outcomes (e.g., percent change in motor seizures, total seizures, hospitalizations, seizure clusters) across time points up to Week 72, and removed several previously reported outcomes.SummaryDifference5%

- Check22 days agoChange DetectedSite-wide version update from v3.4.3 to v3.5.0; no study details or user-facing content appear to be modified.SummaryDifference0.2%

- Check29 days agoChange DetectedUpdated view shows cosmetic UI and layout adjustments (header styling and spacing). Core study data such as enrollment, eligibility criteria, outcomes, and status appear unchanged.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now shows 'Results Submitted' replacing 'No Results Posted,' and the revision is updated to v3.4.3.SummaryDifference0.3%

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.